Pall Corporation Expands Pharmaceutical and Biopharmaceutical Solutions with Acquisition of ATMI, Inc.
11 Mar 2014

Pall Corporation, a global leader in filtration, separation and purification, today announced it has completed the acquisition of the LifeSciences business of ATMI, Inc..

The ATMI LifeSciences portfolio acquired by Pall encompasses custom-engineered, flexible packaging solutions, single-use storage systems, mixers and bioreactors for the pharmaceutical and biopharmaceutical industries. This includes well-known brands such as Integrity® single-use technologies and Newform™ ultra clean sterile packaging.

“The acquisition of ATMI LifeSciences broadens our upstream presence in bioprocessing and complements our established downstream capabilities,” said Larry Kingsley, Pall Chairman and CEO. “Combined with the recent acquisitions of single-use innovators Medistad Holding B.V. and SoloHill Engineering, Inc. and our already solid portfolio of biopharmaceutical solutions, the addition of the ATMI LifeSciences assets positions us well to capitalize on opportunities in the rapidly growing single-use market segment.”

Request Info


Company website

Pall Life Sciences Products - Biopharmaceutical Division
profile photo

Sarah Thomas
Editorial Assistant